This content is machine translated The AMALFI study and the limits of digital screening for atrial fibrillation Remote monitoring for atrial fibrillation: lots of detection, little stroke prevention? Atrial fibrillation (AF) is often asymptomatic, increases stroke risk and can be treated with anticoagulation – so the logic of screening seems compelling. New patches, loop recorders and smartwatches promise...…
View Post 12 min This content is machine translated Anticoagulation after cerebral hemorrhage with atrial fibrillation What PRESTIGE-AF answers – and what remains unanswered According to study results, direct oral anticoagulation (DOAC) can effectively prevent ischemic strokes in survivors of intracerebral hemorrhage with atrial fibrillation. However, the results also show a relevant increase in...…
View Post 5 min This content is machine translated Atrial fibrillation Anticoagulation after catheter ablation – for how long? In selected groups of patients with atrial fibrillation, ablation can lead to an improvement in symptoms and/or prognosis. To avoid complications, anticoagulation before, during and after ablation should be criteria-driven....…
View Post 11 min This content is machine translated Late-Breaking Science Antithrombotics & rhythm The ESC Congress 2025 in Madrid presented several studies in hot-line and late-breaking sessions that have a direct impact on the care of patients with atrial fibrillation, coronary heart disease,...…
View Post 3 min This content is machine translated Antiphospholipid syndrome Preferably anticoagulate with VKA or heparin Antiphospholipid syndrome (APS) is an acquired thrombophilia and is associated with a high risk of venous, arterial or microvascular thrombosis. In APS with thrombotic manifestations, lifelong anticoagulation is generally indicated.…
View Post 7 min This content is machine translated Anticoagulation for atrial fibrillation New ESC guideline has adapted recommendations Atrial fibrillation is the most common persistent cardiac arrhythmia in adults. In the new guidelines for the management of atrial fibrillation, the European Society of Cardiology (ESC) pays particular attention…
View Post 9 min This content is machine translated Screening for atrial fibrillation is not a sure-fire success Oral anticoagulation in AHRE risky and ineffective Anticoagulants increase the risk of bleeding but do not prevent strokes in patients with atrial high rate episodes (AHRE) and without ECG-diagnosed atrial fibrillation. This is the conclusion of the…
View Post 3 min This content is machine translated Anticoagulation for atrial fibrillation Large-scale cohort study compares two DOAKs The results of the prospective observational study showed that in patients over 65 years of age with atrial fibrillation, treatment with rivaroxaban was associated with a significantly increased risk of severe…
View Post 15 min This content is machine translated Therapy of venous occlusions Endovascular interventions – option for patients with more pronounced symptoms Deep vein thrombosis develops in 1/1000 inhabitants of Western Europe per year. In the acute phase, it is critical to prevent the complication of pulmonary artery embolism. This is now… CME-Test
View Post 3 min This content is machine translated Cardiovascular diseases New study data on primary prophylaxis with ASA: carefully weigh benefits and risks Acetylsalicylic acid (ASA) has long been established for the secondary prevention of cardiovascular events. In contrast, ASA administration for primary prevention is controversial. While European experts tend to advise against…
View Post 15 min This content is machine translated Therapy of venous occlusions Endovascular interventions – option for patients with more pronounced symptoms Deep vein thrombosis develops in 1/1000 inhabitants of Western Europe per year. In the acute phase, it is critical to prevent the complication of pulmonary artery embolism. This is now… CME-Test
